THE RISK OF TRANSFORMATION OF FOLLICULAR LYMPHOMA “TRANSFORMED” BY RITUXIMAB: THE ARISTOTLE STUDY PROMOTED BY THE EUROPEAN LYMPHOMA INSTITUTE-Reference-Cited by-同舟云学术

THE RISK OF TRANSFORMATION OF FOLLICULAR LYMPHOMA “TRANSFORMED” BY RITUXIMAB: THE ARISTOTLE STUDY PROMOTED BY THE EUROPEAN LYMPHOMA INSTITUTE

Published:2017-06 Issue: Volume:35 Page:115-116
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Federico M.¹,Caballero D.²,Marcheselli L.¹,Tarantino V.¹,Sarkozy C.³,Lopez Guillermo A.⁴,Wondergem M.⁵,Kimby E.⁶,Rusconi C.⁷,Zucca E.⁸,Montoto S.⁹,da Silva M.G.¹⁰,Aurer I.¹¹,Paszkiewicz-Kozik E.¹²,Cartron G.¹³,Morschhauser F.¹⁴,Alcoceba M.²,Chamuleau M.⁵,Lockmer S.⁶,Minoia C.¹⁵,Issa D.¹⁶,Alonso S.²,Conte L.¹⁷,Salles G.³,Coiffier B.³

Affiliation:

1. Department of Diagnostic, Clinical and Public Health Medicine; University of Modena e Reggio Emilia; Modena Italy

2. Department of Hematology; Hospital Universitario de Salamanca; Salamanca Spain

3. Department of Hematology, Hospices Civils de Lyon; Universite Claude Bernard Lyon-1Pierre Bénite Cedex; France

4. Department of Hematology; Hospital Clinic, IDIBAPS, CIBERONC; Barcelona Spain

5. Department of Hematology; VU University Medical Center; Amsterdam Netherlands

6. Department of Hematology; Karolinska Institute; Stockholm Sweden

7. Division of Hematology; Niguarda Hospital; Milan Italy

8. Oncology Institute of Southern Switzerland; Ospedale San Giovanni; Bellinzona Switzerland

9. Department of Hematology; Barts Cancer Institute, QMUL; London UK

10. Department of Hematology; Instituto Português de Oncologia de Lisboa; Lisbon Portugal

11. Division of Hematology; University Hospital Centre Zagreb; Zagreb Croatia

12. Department of Lymphoid Malignancies; The Maria Sklodowska-Curie Memorial Institute and Oncology Centre; Warszawa Poland

13. Department of Hematology; CHU Montpellier; Montpellier France

14. Department of Clinical Hematology, CHU Lille, Unite GRITA; Universite de Lille 2; Lille France

15. Haematology Unit, National Cancer Research Centre; Istituto Tumori "Giovanni Paolo II"; Bari Italy

16. Department of Hematology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch; Netherlands

17. Interdisciplinary Laboratory of Applied Research in Medicine (DReAM); University of Salento; Lecce Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2437_104/fullpdf

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of initial, interim and end-of-therapy 18F-FDG PET/CT for predicting transformation risk in follicular lymphoma;Cancer Cell International;2021-07-26

2. Transformed follicular lymphoma in the rituximab era: A report from theSpanishLymphomaOncologyGroup;Hematological Oncology;2019-04

3. Current and future therapeutic approaches for the treatment of follicular lymphoma;Expert Review of Anticancer Therapy;2018-07-16

4. Treatment of localized-stage follicular lymphoma;European Journal of Haematology;2018-06-25

5. Novel acquisitions on biology and management of transformed follicular lymphoma;Hematological Oncology;2018-03-30